Preservation of ovarian function with goserelin in young breast cancer patients: Does it hamper the effect of neoadjuvant chemotherapy?

被引：0
|
作者：
Wang, S. Y. [1 ]
Wang, S. [1 ]
机构：
[1] Peking Univ, Breast Surg, Peoples Hosp, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.03.045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
107P
引用
下载
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy?
    Kim, Jiyoung
    Kim, Minkook
    Lee, Jun Ho
    Lee, Hyunchul
    Lee, Se Kyung
    Bae, Soo Youn
    Jun, Si-Youl
    Kil, Won Ho
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    BREAST, 2014, 23 (05): : 670 - 675
  • [2] Temporary Ovarian Suppression With Goserelin and Ovarian Function Protection in Patients With Breast Cancer Undergoing Chemotherapy
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3339 - 3340
  • [3] Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer
    Kim, Sung Eun
    Kim, Won-Ji
    Choi, DooSeok
    Lee, Dong-Yun
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (02) : 231 - 237
  • [4] Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer
    Sung Eun Kim
    Won-Ji Kim
    DooSeok Choi
    Dong-Yun Lee
    Breast Cancer Research and Treatment, 2023, 198 : 231 - 237
  • [5] Goserelin and preservation of ovarian function among breast cancer patients treated with adjuvant cytotoxic chemotherapy: results from a randomised trial.
    Sverrisdottir, A.
    Nystedt, M.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S110 - S110
  • [6] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    A. Sverrisdottir
    M. Nystedt
    H. Johansson
    T. Fornander
    Breast Cancer Research and Treatment, 2009, 117
  • [7] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    Sverrisdottir, A.
    Nystedt, M.
    Johansson, H.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 561 - 567
  • [8] Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy
    Ismail-Khan, R.
    Minton, S.
    Cox, C.
    Sims, I.
    Lacevic, M.
    Gross-King, M.
    Xu, P.
    Carter, B.
    Munster, P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients
    Del Mastro, L
    Catzeddu, T
    Boni, L
    Bell, C
    Sertoli, MR
    Bighin, C
    Clavarezza, M
    Testa, D
    Venturini, M
    ANNALS OF ONCOLOGY, 2006, 17 (01) : 74 - 78
  • [10] Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
    Wang, Siyuan
    Pei, Lin
    Hu, Taobo
    Jia, Mei
    Wang, Shu
    HUMAN REPRODUCTION, 2021, 36 (04) : 976 - 986
12345